Clinical Trials Logo

Clinical Trial Summary

Clinical study of anti-tumor necrosis factor therapy in patients with Takayasu arteritis.

This study is single arm (anti Tumor necrosis factor therapy only) clinical trial. Enrolled patients will be 11


Clinical Trial Description

Clinical study of anti-tumor necrosis factor therapy in patients with Takayasu arteritis.

This study is single arm (anti Tumor necrosis factor therapy only) clinical trial. Enrolled patients will be 11 patients with active takayasu's arteritis ;


Study Design


Related Conditions & MeSH terms


NCT number NCT02457585
Study type Interventional
Source Seoul National University Hospital
Contact Sang Jin Lee, MD
Phone 82-10-8623-2648
Email dream1331@naver.com
Status Recruiting
Phase Phase 2
Start date March 2015
Completion date April 2018

See also
  Status Clinical Trial Phase
Recruiting NCT02257866 - Studies of the Natural History, Pathogenesis, and Outcome of Idiopathic Systemic Vasculitis
Completed NCT02190916 - Vasculitis Illness Perception (VIP) Study N/A
Recruiting NCT01241305 - One-Time DNA Study for Vasculitis
Completed NCT02190942 - VCRC Patient Contact Registry Patient-Reported Data Validation Study
Recruiting NCT03494062 - Exercise in Juvenile Takayasu Disease N/A
Completed NCT02190929 - Educational Needs of Patients With Systemic Vasculitis N/A
Completed NCT02476292 - Impact of Vasculitis on Employment and Income N/A
Recruiting NCT03372980 - A Registry Study on Biomarkers of Takayasu's Arteritis (ARSBTA)
Completed NCT02176070 - Reproductive Health in Men and Women With Vasculitis N/A
Completed NCT00556439 - Abatacept for Treating Adults With Giant Cell Arteritis and Takayasu's Arteritis Phase 2
Completed NCT01795456 - Carotid Artery Neovascularization in Takayasu's and Giant Cell Arteritis N/A
Completed NCT00315471 - Determining Disease Activity Biomarkers in Individuals With Takayasu's Arteritis